- Home
- EIG vs AQST Comparison
EIG vs AQST Comparison
Compare EIG & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EIG
- AQST
- Stock Information
- Founded
- EIG 2000
- AQST 2004
- Country
- EIG United States
- AQST United States
- Employees
- EIG N/A
- AQST N/A
- Industry
- EIG Property-Casualty Insurers
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- EIG Finance
- AQST Health Care
- Exchange
- EIG Nasdaq
- AQST Nasdaq
- Market Cap
- EIG 986.1M
- AQST 809.3M
- IPO Year
- EIG 2007
- AQST 2018
- Fundamental
- Price
- EIG $40.01
- AQST $6.23
- Analyst Decision
- EIG
- AQST Strong Buy
- Analyst Count
- EIG 0
- AQST 7
- Target Price
- EIG N/A
- AQST $10.00
- AVG Volume (30 Days)
- EIG 256.6K
- AQST 3.0M
- Earning Date
- EIG 10-30-2025
- AQST 11-05-2025
- Dividend Yield
- EIG 3.23%
- AQST N/A
- EPS Growth
- EIG N/A
- AQST N/A
- EPS
- EIG 2.58
- AQST N/A
- Revenue
- EIG $904,800,000.00
- AQST $43,397,000.00
- Revenue This Year
- EIG $2.62
- AQST N/A
- Revenue Next Year
- EIG N/A
- AQST $51.39
- P/E Ratio
- EIG $15.36
- AQST N/A
- Revenue Growth
- EIG 1.69
- AQST N/A
- 52 Week Low
- EIG $35.73
- AQST $2.12
- 52 Week High
- EIG $54.19
- AQST $7.55
- Technical
- Relative Strength Index (RSI)
- EIG 52.59
- AQST 54.90
- Support Level
- EIG $38.42
- AQST $5.73
- Resistance Level
- EIG $39.88
- AQST $6.17
- Average True Range (ATR)
- EIG 0.73
- AQST 0.40
- MACD
- EIG 0.23
- AQST 0.03
- Stochastic Oscillator
- EIG 96.42
- AQST 85.83
About EIG Employers Holdings Inc
Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through its wholly owned subsidiaries.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.